We are currently looking to understand the pharma distribution strategy adopted by orphan drug (drugs to treat rare disease) manufacturers in australia. We know that australian market is dominated by three major cso distributors (api, sigma and x b) and major generic drug manufacturers prefer to engage with these 3 wholesalers as they have the maximum distribution point of sales and are required to supply drugs listed in pbs. 1. So based on this, would like to know if orphan drug manufacturers also use these wholesalers or do they prefer direct distribution using dhl or world couriers, or any other strategy? 2. Would like to get some case specific to orphan drug distribution in australia. Thank you and looking forward.
Leonard |Independent Consultant
I am not qualified for this project...7.5 Hours Later
This client appears interested in an expert with specific knowledge of orphan drug distribution in A...7.7 Hours Later
C.P. |Independent Pharmaceuticals Professional
Dear Sir/Madam, I am Shastry, from Pharma Synergies, India. I am an 'Independent *****ma B...1.2 Days Later